6 March 2018 - Here is a hugely winning issue for President Donald Trump that would deal with a gross trading abuse and simultaneously advance his goal of reducing the prices of prescription drugs: insist that foreign buyers of American pharmaceuticals--almost without exception government agencies--pay their fair share of the research and development costs of these medicines. 

Currently, Americans are subsidising overseas users of our drugs.

Here's how that works. The average price of successfully bringing a new medicine to market in the U.S. is about $2.4 billion. The entire approval process takes some 12 years before a drug receives its final green light. The expenses include all the would-be medicines that fail to make it out of the research labs or falter during the FDA's expensive, time-consuming clinical trials.

Read Forbes magazine article